What is he best known for?
The fields of study he is best known for:
Virology, Virus, Influenza A virus, Coronavirus and Influenza A virus subtype H5N1 are his primary areas of study.
His research integrates issues of Pandemic and H5N1 genetic structure in his study of Virology.
The study incorporates disciplines such as Epitope and Phylogenetics in addition to Virus.
His studies in Phylogenetics integrate themes in fields like Genome and Phylogenetic tree.
The concepts of his Coronavirus study are interwoven with issues in Middle East respiratory syndrome coronavirus, Plasma protein binding, Heptad repeat, Lipid bilayer fusion and Betacoronavirus.
His Genetics research incorporates themes from Reassortment and Microbiology.
His most cited work include:
- A Novel Coronavirus from Patients with Pneumonia in China, 2019. (10418 citations)
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. (7137 citations)
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. (5012 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Virology, Virus, Influenza A virus, Influenza A virus subtype H5N1 and Genetics.
His Virology research is multidisciplinary, incorporating elements of Epitope, Antibody, Immunology and Coronavirus.
His work in Epitope tackles topics such as Major histocompatibility complex which are related to areas like Cytotoxic T cell and CD8.
He interconnects Pandemic and Phylogenetics in the investigation of issues within Virus.
The various areas that he examines in his Influenza A virus study include Hemagglutinin, Reassortment and Microbiology.
His research in Genetics is mostly focused on Gene.
He most often published in these fields:
- Virology (67.50%)
- Virus (46.48%)
- Influenza A virus (19.09%)
What were the highlights of his more recent work (between 2019-2021)?
- Virology (67.50%)
- Coronavirus disease 2019 (5.80%)
- Severe acute respiratory syndrome coronavirus 2 (5.23%)
In recent papers he was focusing on the following fields of study:
George F. Gao mainly investigates Virology, Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2, Virus and 2019-20 coronavirus outbreak.
The concepts of his Virology study are interwoven with issues in Antibody, Recombinant DNA and Coronavirus.
His research in Antibody tackles topics such as Immune system which are related to areas like Influenza A virus.
His Coronavirus research incorporates elements of Betacoronavirus and Phylogenetic tree.
His work in the fields of Coronavirus disease 2019, such as Pandemic, intersects with other areas such as Transmission.
Virus is the subject of his research, which falls under Genetics.
Between 2019 and 2021, his most popular works were:
- A Novel Coronavirus from Patients with Pneumonia in China, 2019. (10418 citations)
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. (7137 citations)
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. (5012 citations)
In his most recent research, the most cited papers focused on:
His primary areas of investigation include Virology, Virus, Coronavirus, Coronavirus disease 2019 and Severe acute respiratory syndrome coronavirus 2.
His research combines Antibody and Virology.
He has included themes like RNA polymerase and Polymerase in his Virus study.
George F. Gao combines subjects such as Middle East respiratory syndrome coronavirus, Betacoronavirus and Genetics with his study of Coronavirus.
The Betacoronavirus study combines topics in areas such as Phylogenetic tree, Genome, Viral pneumonia, Phylogenetics and Sanger sequencing.
His Coronavirus disease 2019 study integrates concerns from other disciplines, such as Outbreak, 2019-20 coronavirus outbreak and Pneumonia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
